The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Preclinical Isolated Organ Perfusion System-Global Market Insights and Sales Trends 2025
Synopsis
Isolated organ perfusion involves maintaining an organ in viable status, either by single pass or recirculation with the medium. Isolated organ perfusion has been documented in distribution studies involving several organs including lung, kidney and brain. These isolated organ perfusion techniques allow higher concentrations of chemotherapy to be delivered to the targeted organ while ensuring the vitality of other organs.
The global Preclinical Isolated Organ Perfusion System market size is expected to reach US$ 827.3 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Preclinical Isolated Organ Perfusion System in various end use industries. The expanding demands from the Industrial Laboratories and CROs, Academic and Government Research Institutes and Others,, are propelling Preclinical Isolated Organ Perfusion System market. Isolated Heart Perfusion Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Isolated Abdominal Organ Perfusion Systems segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preclinical Isolated Organ Perfusion System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preclinical Isolated Organ Perfusion System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preclinical Isolated Organ Perfusion System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preclinical Isolated Organ Perfusion System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preclinical Isolated Organ Perfusion System covered in this report include World Precision Instruments, Radnoti, MDE GmbH, Harvard Bioscience, EMKA Technologies, Danish Myo Technology, ADInstruments and Experimetria, etc.
The global Preclinical Isolated Organ Perfusion System market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
World Precision Instruments
Radnoti
MDE GmbH
Harvard Bioscience
EMKA Technologies
Danish Myo Technology
ADInstruments
Experimetria
Global Preclinical Isolated Organ Perfusion System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preclinical Isolated Organ Perfusion System market, Segment by Type:
Isolated Heart Perfusion Systems
Isolated Abdominal Organ Perfusion Systems
Isolated Lung Perfusion Systems
Others
Global Preclinical Isolated Organ Perfusion System market, by Application
Industrial Laboratories and CROs
Academic and Government Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preclinical Isolated Organ Perfusion System companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Isolated organ perfusion involves maintaining an organ in viable status, either by single pass or recirculation with the medium. Isolated organ perfusion has been documented in distribution studies involving several organs including lung, kidney and brain. These isolated organ perfusion techniques allow higher concentrations of chemotherapy to be delivered to the targeted organ while ensuring the vitality of other organs.
The global Preclinical Isolated Organ Perfusion System market size is expected to reach US$ 827.3 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Preclinical Isolated Organ Perfusion System in various end use industries. The expanding demands from the Industrial Laboratories and CROs, Academic and Government Research Institutes and Others,, are propelling Preclinical Isolated Organ Perfusion System market. Isolated Heart Perfusion Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Isolated Abdominal Organ Perfusion Systems segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preclinical Isolated Organ Perfusion System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preclinical Isolated Organ Perfusion System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preclinical Isolated Organ Perfusion System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preclinical Isolated Organ Perfusion System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preclinical Isolated Organ Perfusion System covered in this report include World Precision Instruments, Radnoti, MDE GmbH, Harvard Bioscience, EMKA Technologies, Danish Myo Technology, ADInstruments and Experimetria, etc.
The global Preclinical Isolated Organ Perfusion System market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
World Precision Instruments
Radnoti
MDE GmbH
Harvard Bioscience
EMKA Technologies
Danish Myo Technology
ADInstruments
Experimetria
Global Preclinical Isolated Organ Perfusion System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preclinical Isolated Organ Perfusion System market, Segment by Type:
Isolated Heart Perfusion Systems
Isolated Abdominal Organ Perfusion Systems
Isolated Lung Perfusion Systems
Others
Global Preclinical Isolated Organ Perfusion System market, by Application
Industrial Laboratories and CROs
Academic and Government Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preclinical Isolated Organ Perfusion System companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Preclinical Isolated Organ Perfusion System
1.1 Preclinical Isolated Organ Perfusion System Market Overview
1.1.1 Preclinical Isolated Organ Perfusion System Product Scope
1.1.2 Preclinical Isolated Organ Perfusion System Market Status and Outlook
1.2 Global Preclinical Isolated Organ Perfusion System Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Preclinical Isolated Organ Perfusion System Market Size by Region (2018-2029)
1.4 Global Preclinical Isolated Organ Perfusion System Historic Market Size by Region (2018-2023)
1.5 Global Preclinical Isolated Organ Perfusion System Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Preclinical Isolated Organ Perfusion System Market Size (2018-2029)
1.6.1 North America Preclinical Isolated Organ Perfusion System Market Size (2018-2029)
1.6.2 Europe Preclinical Isolated Organ Perfusion System Market Size (2018-2029)
1.6.3 Asia-Pacific Preclinical Isolated Organ Perfusion System Market Size (2018-2029)
1.6.4 Latin America Preclinical Isolated Organ Perfusion System Market Size (2018-2029)
1.6.5 Middle East & Africa Preclinical Isolated Organ Perfusion System Market Size (2018-2029)
2 Preclinical Isolated Organ Perfusion System Market by Type
2.1 Introduction
2.1.1 Isolated Heart Perfusion Systems
2.1.2 Isolated Abdominal Organ Perfusion Systems
2.1.3 Isolated Lung Perfusion Systems
2.1.4 Others
2.2 Global Preclinical Isolated Organ Perfusion System Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Preclinical Isolated Organ Perfusion System Historic Market Size by Type (2018-2023)
2.2.2 Global Preclinical Isolated Organ Perfusion System Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Preclinical Isolated Organ Perfusion System Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Preclinical Isolated Organ Perfusion System Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Preclinical Isolated Organ Perfusion System Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Preclinical Isolated Organ Perfusion System Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Preclinical Isolated Organ Perfusion System Revenue Breakdown by Type (2018-2029)
3 Preclinical Isolated Organ Perfusion System Market Overview by Application
3.1 Introduction
3.1.1 Industrial Laboratories and CROs
3.1.2 Academic and Government Research Institutes
3.1.3 Others
3.2 Global Preclinical Isolated Organ Perfusion System Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Preclinical Isolated Organ Perfusion System Historic Market Size by Application (2018-2023)
3.2.2 Global Preclinical Isolated Organ Perfusion System Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Preclinical Isolated Organ Perfusion System Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Preclinical Isolated Organ Perfusion System Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Preclinical Isolated Organ Perfusion System Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Preclinical Isolated Organ Perfusion System Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Preclinical Isolated Organ Perfusion System Revenue Breakdown by Application (2018-2029)
4 Preclinical Isolated Organ Perfusion System Competition Analysis by Players
4.1 Global Preclinical Isolated Organ Perfusion System Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preclinical Isolated Organ Perfusion System as of 2022)
4.3 Date of Key Players Enter into Preclinical Isolated Organ Perfusion System Market
4.4 Global Top Players Preclinical Isolated Organ Perfusion System Headquarters and Area Served
4.5 Key Players Preclinical Isolated Organ Perfusion System Product Solution and Service
4.6 Competitive Status
4.6.1 Preclinical Isolated Organ Perfusion System Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 World Precision Instruments
5.1.1 World Precision Instruments Profile
5.1.2 World Precision Instruments Main Business
5.1.3 World Precision Instruments Preclinical Isolated Organ Perfusion System Products, Services and Solutions
5.1.4 World Precision Instruments Preclinical Isolated Organ Perfusion System Revenue (US$ Million) & (2018-2023)
5.1.5 World Precision Instruments Recent Developments
5.2 Radnoti
5.2.1 Radnoti Profile
5.2.2 Radnoti Main Business
5.2.3 Radnoti Preclinical Isolated Organ Perfusion System Products, Services and Solutions
5.2.4 Radnoti Preclinical Isolated Organ Perfusion System Revenue (US$ Million) & (2018-2023)
5.2.5 Radnoti Recent Developments
5.3 MDE GmbH
5.3.1 MDE GmbH Profile
5.3.2 MDE GmbH Main Business
5.3.3 MDE GmbH Preclinical Isolated Organ Perfusion System Products, Services and Solutions
5.3.4 MDE GmbH Preclinical Isolated Organ Perfusion System Revenue (US$ Million) & (2018-2023)
5.3.5 Harvard Bioscience Recent Developments
5.4 Harvard Bioscience
5.4.1 Harvard Bioscience Profile
5.4.2 Harvard Bioscience Main Business
5.4.3 Harvard Bioscience Preclinical Isolated Organ Perfusion System Products, Services and Solutions
5.4.4 Harvard Bioscience Preclinical Isolated Organ Perfusion System Revenue (US$ Million) & (2018-2023)
5.4.5 Harvard Bioscience Recent Developments
5.5 EMKA Technologies
5.5.1 EMKA Technologies Profile
5.5.2 EMKA Technologies Main Business
5.5.3 EMKA Technologies Preclinical Isolated Organ Perfusion System Products, Services and Solutions
5.5.4 EMKA Technologies Preclinical Isolated Organ Perfusion System Revenue (US$ Million) & (2018-2023)
5.5.5 EMKA Technologies Recent Developments
5.6 Danish Myo Technology
5.6.1 Danish Myo Technology Profile
5.6.2 Danish Myo Technology Main Business
5.6.3 Danish Myo Technology Preclinical Isolated Organ Perfusion System Products, Services and Solutions
5.6.4 Danish Myo Technology Preclinical Isolated Organ Perfusion System Revenue (US$ Million) & (2018-2023)
5.6.5 Danish Myo Technology Recent Developments
5.7 ADInstruments
5.7.1 ADInstruments Profile
5.7.2 ADInstruments Main Business
5.7.3 ADInstruments Preclinical Isolated Organ Perfusion System Products, Services and Solutions
5.7.4 ADInstruments Preclinical Isolated Organ Perfusion System Revenue (US$ Million) & (2018-2023)
5.7.5 ADInstruments Recent Developments
5.8 Experimetria
5.8.1 Experimetria Profile
5.8.2 Experimetria Main Business
5.8.3 Experimetria Preclinical Isolated Organ Perfusion System Products, Services and Solutions
5.8.4 Experimetria Preclinical Isolated Organ Perfusion System Revenue (US$ Million) & (2018-2023)
5.8.5 Experimetria Recent Developments
6 North America
6.1 North America Preclinical Isolated Organ Perfusion System Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Preclinical Isolated Organ Perfusion System Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Isolated Organ Perfusion System Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Preclinical Isolated Organ Perfusion System Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Isolated Organ Perfusion System Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Preclinical Isolated Organ Perfusion System Market Dynamics
11.1 Preclinical Isolated Organ Perfusion System Industry Trends
11.2 Preclinical Isolated Organ Perfusion System Market Drivers
11.3 Preclinical Isolated Organ Perfusion System Market Challenges
11.4 Preclinical Isolated Organ Perfusion System Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
